Paavo Koivisto16 Apr 2025 20:10
Paavo_Koivisto
IR Manager @ Faron
42 min
Hello everyone,
The discussion has been very active again, and it is good to clarify and remind you of a few things.
This week we published the highlights of the Phase II study, and the detailed results have been submitted to the 2025 ASCO Annual Meeting Abstract Policies, Embargoes & Exceptions | ASCO Annual Meeting . As such, the detailed results are under embargo. This is a very important data package that has been long awaited by many parties and the company. It is industry standard to present these results at major conferences.
"ASCO would strongly prefer that the company's press release:
summarize study data cited in the abstract in a qualitative fashion rather than providing specific quantitative information ;
avoid interpretations about the implications of the data for practice; and
note that full data has been submitted to the ASCO Meeting.”
The ASCO abstracts will be published next week on the 23rd, and then we will know, for example, ASCO's position, whether the abstract has been accepted and to what extent. Once we have this information, we will hold interviews where we can answer at least some of the questions you have been asking and provide more information about the schedule.
So we can only talk about the Phase II results at a high level: Inside Information: Faron Announces Positive Phase II results in higher-risk myelodysplastic syndrome – Faron and as a reminder that some patients are in the early stages of their treatment. Once we have published the detailed results, we will present these very widely and thoroughly.
There has also been discussion about the owner register and its changes. In connection with the website update, we renewed our IR tool, which includes, among other things, owner lists for the website. We are listed on two stock exchanges: London and Helsinki. We receive detailed owner information from the Helsinki Stock Exchange daily via Euroclear. In London, the situation is different and the ownership information is behind nominee registered banks (nominee register / di-holder). We have over a hundred nominee registered banks, and the information does not come automatically, but by request. Thanks to the new system, we have built a pipeline that will allow us to receive quarterly information from all these nominee registered banks and import it into our lists. This data has not been available before. The share list on the website shows the item “verified”, which indicates the time when the latest owner information was entered. If it has been a long time since the previous update, the changes may appear significant. In the future, foreign owners will be updated regularly via this pipeline, and we will be able to offer you a more accurate picture of the owners.
There are some very important milestones coming up this year and you will have plenty to follow too! We will be holding interviews and webcasts with external experts. R&D day and CMD
Sign In
Follow the stocks
